This trial will test whether an electronic best practice advisory system, which notifies clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients, is more effective than usual care in stimulating appropriate medication prescription for patients with heart failure and a reduced ejection fraction.
1 Primary · 4 Secondary · Reporting Duration: 1 year
Active Control
Experimental Treatment
5000 Total Participants · 2 Treatment Groups
Primary Treatment: Alert when provider is entering orders · No Placebo Group · N/A
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: